2021
DOI: 10.3390/ma14112939
|View full text |Cite
|
Sign up to set email alerts
|

Application of Advanced Nanomaterials for Kidney Failure Treatment and Regeneration

Abstract: The implementation of nanomedicine not only provides enhanced drug solubility and reduced off-target adverse effects, but also offers novel theranostic approaches in clinical practice. The increasing number of studies on the application of nanomaterials in kidney therapies has provided hope in a more efficient strategy for the treatment of renal diseases. The combination of biotechnology, material science and nanotechnology has rapidly gained momentum in the realm of therapeutic medicine. The establishment of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(15 citation statements)
references
References 131 publications
(178 reference statements)
0
15
0
Order By: Relevance
“…Various nanomaterials, including carbon nanotubes, nanofibrous membranes, and mesoporous silica nanoparticles, have been used in medical field. 29,30 However, these “hard” materials have been limited in clinic because of their poor biocompatibility, low solubility, or slow metabolic rate. Nucleic acid-based materials are flexible, highly biocompatible, and easy to be metabolized, and thus were considered as useful “soft” materials which aroused the attention of many researchers.…”
Section: Resultsmentioning
confidence: 99%
“…Various nanomaterials, including carbon nanotubes, nanofibrous membranes, and mesoporous silica nanoparticles, have been used in medical field. 29,30 However, these “hard” materials have been limited in clinic because of their poor biocompatibility, low solubility, or slow metabolic rate. Nucleic acid-based materials are flexible, highly biocompatible, and easy to be metabolized, and thus were considered as useful “soft” materials which aroused the attention of many researchers.…”
Section: Resultsmentioning
confidence: 99%
“…One of the challenges is the poor target tissue distribution for immunosuppressive drugs [ 56 ]. However, with the emergence of nanotechnology, potential nanomaterials with special physiochemical properties are being developed and applied for treating various diseases including glomerulonephritis [ 57 ]. With better penetration of loaded drugs, clinical outcomes could be more likely associated with their therapeutic effects in the absence of tissue barrier, which may lead to better prediction model performance due to stronger connection between drugs and outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…New technologies are also being employed to tackle the problem of CKD. Nanotechnology is being used in research settings as a tool to identify and treat diverse kidney diseases [ 22 , 23 ] along with new genetic technology [ 24 , 25 ]. New treatment strategies are also emerging.…”
Section: Discussionmentioning
confidence: 99%